Differential effects of enalapril–felodipine versus enalapril–lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension

Rumantir, 1999, Neural mechanisms in human obesity-related hypertension, J Hypertens, 17, 1125, 10.1097/00004872-199917080-00012 Grassi, 2000, Adrenergic and reflex abnormalities in obesity-related hypertension, Hypertension, 36, 538, 10.1161/01.HYP.36.4.538 Rahmouni, 2005, Obesity-associated hypertension: new insights into mechanisms, Hypertension, 45, 9, 10.1161/01.HYP.0000151325.83008.b4 Esler, 2006, Mechanisms of sympathetic activation in obesity-related hypertension, Hypertension, 48, 787, 10.1161/01.HYP.0000242642.42177.49 Feldstein, 2009, The complex interaction between overweight, obesity and the sympathetic nervous system, J Am Soc Hypertens, 3, 353, 10.1016/j.jash.2009.10.001 Mancia, 2013, 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 34, 2159, 10.1093/eurheartj/eht151 Reisin, 2015, Treatment: special conditions. Metabolic syndrome: obesity and the hypertension connection, J Am Soc Hypertens, 9, 156, 10.1016/j.jash.2014.12.015 Grassi, 2015, The sympathetic nervous system alterations in human hypertension, Circ Res, 116, 976, 10.1161/CIRCRESAHA.116.303604 Hall, 2015, Obesity-related hypertension: interaction of neurohumoral and renal mechanisms, Circ Res, 116, 991, 10.1161/CIRCRESAHA.116.305697 Mancia, 2014, The autonomic nervous system and hypertension, Circ Res, 114, 1804, 10.1161/CIRCRESAHA.114.302524 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Park, 1996, Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography, J Am Soc Echocardiogr, 9, 119, 10.1016/S0894-7317(96)90019-X Grassi, 2003, Short- versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension, Hypertension, 41, 558, 10.1161/01.HYP.0000058003.27729.5A Hjemdahl, 1979, Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method, Life Sci, 25, 131, 10.1016/0024-3205(79)90384-9 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man, Diabetologia, 28, 412, 10.1007/BF00280883 Groppelli, 1992, Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-h intraarterial blood pressure, Hypertension, 20, 227, 10.1161/01.HYP.20.2.227 Bakris, 2006, Differences in glucose tolerance between fixed dose antihypertensive drug combinations in people with metabolic syndrome, Diab Care, 29, 2592, 10.2337/dc06-1373 Mancia, 1983, Arterial baroreflex in humans, 755 Todd, 1992, Felodipine: a review of the pharmacological and therapeutic use of the extend release formulations in cardiovascular disorders, Drugs, 44, 251, 10.2165/00003495-199244020-00008 McGrath, 1995, Clinical equivalence of two tablet formulations of felodipine: a placebo controlled study of 24-hour blood pressure control and tolerability, Eur J Clin Pharmacol, 49, 169, 10.1007/BF00192375 Omboni, 1998, Antihypertensive efficacy of lercanidipine at 2.5, 5, and 10 mg in mild-to-moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators, J Hypertens, 16, 1831, 10.1097/00004872-199816120-00017 McClellan, 2000, Lercanidipine: a review of its using in hypertension, Drugs, 60, 1123, 10.2165/00003495-200060050-00009 Inomata, 2014, Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension, J Hypertens, 32, 1898, 10.1097/HJH.0000000000000270 Grassi, 2004, Counteracting the sympathetic nervous system in hypertension, Curr Opin Nephrol Hypertens, 13, 513, 10.1097/00041552-200409000-00006 Raheja, 2012, Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients, Hypertension, 60, 319, 10.1161/HYPERTENSIONAHA.112.194787 Dorresteijn, 2013, Differential effects of renin-angiotensin system inhibition, sympathoinhibition and blood pressure in obesity-related hypertension: a double-blind, placebo controlled cross-over trial, J Hypertens, 31, 393, 10.1097/HJH.0b013e32835b6c02 Shimada, 2015, Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders, Expert Rev Cardiovasc Ther, 13, 23, 10.1586/14779072.2015.986464 De Ciuceis, 2014, Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study, Blood Press, 23, 330, 10.3109/08037051.2014.901021 Mancia, 2014, Effects on office and home blood pressure of the lercanidipine/enalapril combination in patients with stage 2 hypertension: a European randomized controlled trial, J Hypertens, 32, 1700, 10.1097/HJH.0000000000000239 Gradman, 1998, Long-term efficacy, tolerability and safety of the combination enalapril and felodipine in the treatment of hypertension. Enalapril-Felodipine Factorial Study Group, Clin Ther, 20, 527, 10.1016/S0149-2918(98)80062-3 Hair, 2007, Fixed-dose combination Lercanidipine-Enalapril, Drugs, 67, 95, 10.2165/00003495-200767010-00007 De Champlain, 1998, Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients, J Hypertens, 16, 1357, 10.1097/00004872-199816090-00017 Grassi, 1998, Heart rate as marker of sympathetic activity, J Hypertens, 16, 1635, 10.1097/00004872-199816110-00010 Shen, 2014, Role of the autonomic nervous system in modulating cardiac arrhythmias, Circ Res, 114, 1004, 10.1161/CIRCRESAHA.113.302549